Kidney Injury and Repair Biomarkers in Marathon Runners Sherry G. Mansour, DO, Gagan Verma, MPH, Rachel W. Pata, DPT, CCS, Thomas G. Martin, PhD, Mark A. Perazella, MD, Chirag R. Parikh, MD, PhD  American Journal of Kidney Diseases  Volume 70, Issue 2, Pages 252-261 (August 2017) DOI: 10.1053/j.ajkd.2017.01.045 Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Enrollment chart of runners in the study cohort. Abbreviation: NSAID, nonsteroidal anti-inflammatory drug. American Journal of Kidney Diseases 2017 70, 252-261DOI: (10.1053/j.ajkd.2017.01.045) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Absolute change in serum creatinine level per runner compared to baseline value on day 0. American Journal of Kidney Diseases 2017 70, 252-261DOI: (10.1053/j.ajkd.2017.01.045) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Representative urine microscopy images of samples from 4 runners by time point. American Journal of Kidney Diseases 2017 70, 252-261DOI: (10.1053/j.ajkd.2017.01.045) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Fold increase in biomarker levels compared to baseline on day 0. Abbreviations: IL-6, interleukin 6; IQR, interquartile range; KIM-1, kidney injury molecule 1; MCP-1, monocyte chemoattractant protein 1; NGAL, neutrophil gelatinase-associated lipocalin; TNF-α, tumor necrosis factor α; YKL-40, human cartilage glycoprotein 39. American Journal of Kidney Diseases 2017 70, 252-261DOI: (10.1053/j.ajkd.2017.01.045) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions

American Journal of Kidney Diseases 2017 70, 252-261DOI: (10. 1053/j American Journal of Kidney Diseases 2017 70, 252-261DOI: (10.1053/j.ajkd.2017.01.045) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions